California Institute of Regenerative Medicine (CIRM) Excerpts about Geron’s Decision
November 16th, 2011
No comments
Q&A about Geron’s decision and its implications for the stem cell field Read more…
Archive
Archive for the ‘California Institute for Regenerative Medicine (CIRM)’ Category
StemCells (STEM) awarded CIRM Planning Grant
September 1st, 2011
No comments
Grant to pursue preclinical development of HuCNS-SC Cells for Alzheimer’s disease Read more…
CIRM expands Funding Oppurtunities and Definitions
June 24th, 2011
No comments
The governing board of the California Institute for Regenerative Medicine (CIRM) approved a $30M initiative Read more…
New Chairman of CIRM
June 23rd, 2011
No comments
Jonathan Thomas, PhD, JD, will be the new Chairman of the California Institute for Regenerative Medicine, Read more…
Investor and Over-sight Member nominated for CIRM
May 20th, 2011
No comments
Jonathan Thomas, a founding partner of Saybrook Capital, has been nominated to lead CIRM, Read more…
CIRM funding Troubles
April 4th, 2011
No comments
The collapse of efforts to resolve California’s financial crisis places the $3B stem cell research program perilously close to a serious cash crunch. Read more…
CIRM awards $1.9M to Cedars-Sinai for Spinal Muscular Atrophy (SMA)
February 4th, 2011
No comments
A research team at the Cedars-Sinai Regenerative Medicine Institute has been awarded a $1.9M grant Read more…
Suspending CIRM’s Nominating Vote?
December 14th, 2010
No comments
Calling the process of selecting a chairman for the state’s $3B stem cell research funding agency “fundamentally flawed,” Read more…
$243 M Investment for Stem Cell Disease Teams
August 23rd, 2010
No comments
California’s stem cell research funding agency will fund up to $243 M to help move therapies into clinical trials. Read more…
CIRM Commits $25M to Overcome Immune Rejection of Stem Cell Therapies
July 9th, 2010
No comments
The California Institute for Regenerative Medicine (CIRM) approved $25M to fund 19 projects intended to overcome immune rejection of transplanted stem cells. Read more…
Henry W. McCusker
Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.